Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL study

Holz, FG; Abreu-Gonzalez, R; Bandello, F; Duval, R; O'Toole, L; Pauleikhoff, D; Staurenghi, G; Wolf, A; Lorand, D; Clemens, A; Gmeiner, B

Gmeiner, B (通讯作者),Novartis Pharma GmbH, D-90429 Nurnberg, Germany.

BRITISH JOURNAL OF OPHTHALMOLOGY, 2023; 107 (1): 96

Abstract

Background/rationale Artificial intelligence (AI)-based clinical decision support tools, being developed across multiple fields in medicine, need to b......

Full Text Link